Polytherapy including apremilast and TYK2 inhibitors

MA55799AUndetermined Publication Date: 2022-03-09CELGENE CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA55799
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-04-30
Filing Date
2020-04-30
Publication Date
2022-03-09
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.